Webdisclosure.com

Search

SANOFI-AVENTIS (EPA:SAN) Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis

Directive transparence : information réglementée

26/06/2019 19:30